The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Fed comments provide support ahead of BoE, ECB

Thu, 07th Mar 2013 08:43

The FTSE 100 held on to recent gains on Thursday morning ahead of central-bank policy decisions in the UK and Europe, as comments from the Federal Reserve provided some support.According to the Fed's Beige Book released last night, the US economy expanded at a "modest to moderate pace" at the start of 2013 due to strong car sales, hiring gains and a recovery in the housing sector.The UK benchmark index surged to levels not seen since late 2007 earlier this week a better-than-expected reading of US services activity and a pledge by China to hit its growth targets this year boosted markets.It appears that markets were pausing for breath today ahead of policy decisions from the Bank of England and European Central Bank expected after midday. Speculation has increased over the last month about changes to policy from both sides so investors are likely to sit on their hands and refrain from taking risk until someone makes a move.Overnight, the Bank of Japan voted to keep interest rates and its asset purchase programme unchanged, a decision that was widely expected given the Bank's recent aggressive easing.FTSE 100: Aviva plummets after 'rebasing' diviInsurance giant Aviva was forced to slash to dividend after swinging into the red in 2012, after taking a 3.3bn-pound write-down on a disposal in the US. Aviva also said that its overall situation does not warrant bonuses for executive directors for 2012 or pay rises for 2013. Shares dropped sharply early on.Heading the other way was temporary power and temperature control provider Aggreko after posting a strong performance with trading profit up 13% last year.Insurance provider Standard Life gained after unveiling a windfall dividend worth £302m after delivering substantial growth in profits in 2012 underpinned by strong performance in the UK.British asset management firm Schroders was higher after saying that assets under management (AuM) reached record levels in spite of choppy markets and falling profits.Pharma giant GlaxoSmithKline rose after announcing positive data from a drug study through ViiV Healthcare, a global specialist HIV company set up by GSK in 2009.FTSE 250: National Express dropsTransport group National Express was a heavy faller after reports yesterday said that US investor Elliot Advisors plans to sell over 50m worth of shares, equal to a 9.9% stake.Engineering firm Spirax-Sarco was in demand after proposing a special dividend of 100p per share in addition to an 8.0% rise in the full-year payout, after a 2.0% rise in revenue in 2012.FTSE 100 - RisersAggreko (AGK) 1,932.00p +9.90%IMI (IMI) 1,328.00p +5.23%Admiral Group (ADM) 1,362.00p +2.10%Standard Life (SL.) 380.30p +1.63%Unilever (ULVR) 2,721.00p +1.45%Barclays (BARC) 306.50p +1.44%Reckitt Benckiser Group (RB.) 4,568.00p +1.15%Antofagasta (ANTO) 1,075.00p +1.03%Kazakhmys (KAZ) 560.50p +0.99%Schroders (SDR) 2,056.00p +0.98%FTSE 100 - FallersAviva (AV.) 310.80p -13.62%Melrose Industries (MRO) 260.10p -2.62%Polymetal International (POLY) 958.00p -1.79%British Sky Broadcasting Group (BSY) 874.00p -1.63%Morrison (Wm) Supermarkets (MRW) 259.20p -1.52%Lloyds Banking Group (LLOY) 50.30p -1.41%Serco Group (SRP) 621.50p -0.88%Vodafone Group (VOD) 178.60p -0.78%Legal & General Group (LGEN) 164.90p -0.66%Old Mutual (OML) 208.80p -0.62%FTSE 250 - RisersRegus (RGU) 149.50p +4.18%Spirax-Sarco Engineering (SPX) 2,578.00p +3.00%RIT Capital Partners (RCP) 1,202.00p +2.56%SEGRO (SGRO) 264.60p +2.44%Cobham (COB) 234.20p +2.18%Betfair Group (BET) 702.00p +2.03%Jupiter Fund Management (JUP) 344.60p +1.83%Ashtead Group (AHT) 585.00p +1.74%Rotork (ROR) 2,951.00p +1.58%SIG (SHI) 142.50p +1.50%FTSE 250 - FallersNational Express Group (NEX) 206.90p -10.04%Petropavlovsk (POG) 257.10p -6.34%Hunting (HTG) 889.50p -4.51%Inmarsat (ISAT) 636.50p -4.36%IP Group (IPO) 135.00p -3.23%Balfour Beatty (BBY) 279.30p -2.68%Heritage Oil (HOIL) 192.50p -2.19%International Personal Finance (IPF) 463.90p -2.01%African Barrick Gold (ABG) 241.10p -1.87%Rank Group (RNK) 163.00p -1.69%BC
More News
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.